IGKC is an important component of immunoglobulins, which are involved in innate and adaptive immunity, and is an effective prognostic biomarker for breast cancer and non-small cell lung carcinoma (NSCLC) (17). This evidence concerns the gene IGKC and non-small cell lung carcinoma.